VaccinesNews.net

Vaccines Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

An investigational shingles vaccine, Zostavax, developed by Merck & Co, reduced the total burden of pain and discomfort caused by shingles by 61 percent in a study compared the investigational vaccin ...


An experimental vaccine, called CYT002-NicQb, to treat nicotine addiction has achieved proof of efficacy.. CYT002-NicQb is a therapeutic vaccine in development for the treatment of nicotine addicti ...


MMR ( measles, mumps, and rubella ) vaccine does not seems to increase the risk of Crohn’s disease. It has been hypothesised that the MMR vaccine increases the risk of autism and Crohn's disease. ...


Researchers at New York University ( NYU ) School of Medicine created the first active vaccine that can significantly delay and possibly prevent the onset of a brain disease in mice that is similar to ...


Since Chlamydia pneumoniae is believed to be involved in the pathogenesis of coronary artery disease, ACES study investigated whether antibiotic therapy with Azithromycin ( Zithromax ) to eliminate C ...